Mobile

A study to evaluate the safety and effect of treatment with experimental antiviral drugs in combination with peginterferon α-2a and ribavirin in people with hepatitis C virus who did not respond to tr...

Update Il y a 4 ans
Reference: EUCTR2011-005393-32

A study to evaluate the safety and effect of treatment with experimental antiviral drugs in combination with peginterferon α-2a and ribavirin in people with hepatitis C virus who did not respond to treatment in a previous AbbVie or Abbott combination study

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of this study is to evaluate the safety and antiviral efficacy, defined as the percentage of subjects with sustained virologic response 12 weeks post-dosing (SVR12; HCV RNA < LLOQ 12 weeks after the last dose of study drug).

Inclusion criteria

  • Chronic Hepatitis C Infection

Links